6 Sources
[1]
In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B
Abridge, an AI startup automating medical notes, has secured a $300 million Series E at a $5.3 billion valuation, according to the Wall Street Journal. The round, led by Andreessen Horowitz with participation from Khosla Ventures, follows the company's $250 million February fundraise at a $2.75
[2]
Healthcare startup Abridge raises $300 million, led by VC firm Andreessen Horowitz
June 24 (Reuters) - Healthcare firm Abridge, which uses artificial intelligence to build medical documents, has raised $300 million in a funding round, it said on Tuesday. The funding round was led by venture capital firm Andreessen Horowitz with participation from Khosla Ventures. Founded in
[3]
AI Note-Taking Startup Abridge Raises $300M As Tech To Reduce Physician Burnout Gains Traction
Several well-funded startups have emerged to try to reduce the doctor burnout associated with note-taking and other administrative duties. "We've seen healthcare take up generative AI-centered solutions faster than any other industry," Abridge CEO and co-founder Dr. Shiv Rao told the Journal. His
[4]
Medical AI startup Abridge closes $300M investment at $5.3B valuation - SiliconANGLE
Medical AI startup Abridge closes $300M investment at $5.3B valuation Medical software developer Abridge Inc. today disclosed that it has raised a $300 million funding round led by Andreessen Horowitz. The investment, which also included the participation of Khosla Ventures, values the startup at
[5]
Healthcare startup Abridge tops $5 billion valuation
The latest funding round, aimed at improving revenue cycles and bridging the gap between clinicians and billing teams, was led by venture capital firm Andreessen Horowitz - also known as A16z - with participation from Khosla Ventures.Healthcare firm Abridge, which uses artificial intelligence to
[6]
Abridge Raises $300 Million for AI Medical Note-Taking Tech | PYMNTS.com
The funding values Abridge at $5.3 billion and will help the company develop its tool that uses AI to automate doctors' note-taking, The Wall Street Journal (WSJ) reported Tuesday (June 24). Abridge Co-founder and CEO Dr. Shiv Rao told the WSJ that the new capital will help the company hire
Share
Copy Link
Abridge, an AI-powered medical scribe startup, has raised $300 million in a Series E funding round, doubling its valuation to $5.3 billion in just four months. The company's rapid growth highlights the increasing adoption of AI in healthcare to reduce physician burnout and improve efficiency.
Abridge, a leading AI-powered medical scribe startup, has successfully raised $300 million in a Series E funding round, catapulting its valuation to $5.3 billion
1
. This significant increase comes just four months after its previous fundraising round, which valued the company at $2.75 billion1
. The latest round was led by Andreessen Horowitz, with participation from Khosla Ventures2
.
Source: ET
Founded in 2018 by cardiologist Dr. Shiv Rao, Abridge has quickly established itself as a frontrunner in the AI-powered medical scribe market
3
. The company's success can be attributed to its early entry into the field and its strategic integration with Epic Systems, the dominant health record software1
. Abridge's technology is now utilized by over 150 of the largest health systems in the United States1
.
Source: SiliconANGLE
Abridge's Contextual Reasoning Engine uses ambient-listening technology to record and transcribe doctor-patient conversations, automatically generating medical notes
4
. This AI-driven approach significantly reduces the time physicians spend on administrative tasks, addressing a major pain point in the healthcare industry3
. Dr. Rao noted, "We've seen healthcare take up generative AI-centered solutions faster than any other industry"3
.In the first quarter of 2025, Abridge reported $117 million in contracted annual recurring revenue
1
. This metric includes all signed recurring contracts, even from customers not yet onboarded, indicating strong market demand for their services1
. The company has now raised a total of $757.5 million from investors3
.Alongside the funding announcement, Abridge revealed plans to expand its services into converting medical notes from patient appointments into AI-powered medical codes
1
. This move positions the company in direct competition with startups like CodaMetrix and even its partner, Epic Systems1
. The expansion aims to improve revenue cycles and bridge the gap between clinicians and billing teams5
.Related Stories

Source: PYMNTS
Abridge's success is part of a larger trend of increasing investment in AI healthcare solutions. In 2024, funding for startups at the intersection of AI and healthcare reached $7.5 billion, with 2025 on track to surpass this figure
3
. David George, general partner at Andreessen Horowitz, emphasized Abridge's potential, stating, "While the healthcare system has evolved over the last 30 years, the one constant has been rising costs and the growing burden on clinicians and patients alike"5
.As Abridge continues to grow and expand its services, it is poised to play a significant role in reshaping the healthcare industry. By automating time-consuming administrative tasks, the company aims to allow healthcare professionals to focus more on patient care. With its latest funding and expanded capabilities, Abridge is well-positioned to drive further innovation in the rapidly evolving field of AI-powered healthcare solutions.
Summarized by
Navi
[3]
[4]
11 Jun 2026•Health

30 Jul 2025•Technology

10 Jan 2025•Health

1
Technology

2
Science and Research

3
Technology
